NCT02178293CompletedPhase 4
MISTRAL (Mouthwash In Sore Throat Relief: Antiinflammatory vs. Local Anesthetic Therapy) "Efficacy and Tolerability of Ketoprofen Lysine Salt as a Mouthwash in Acute Phlogosis of the Pharyngeal Cavity; Multicentre, Randomized, Single-blind, Parallel-group Comparison Versus Benzidamine Hydrochloride"
Conditions
Interventions
Drugs
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Boehringer Ingelheim
- Enrollment
- 214
- Primary Endpoint
- Duration of analgesic effects in hours
Study Overview
Brief Summary
A study to in order to verify any differences between the 2 treatment groups in terms of duration of analgesic effects after the first drug intake and time to remission of symptoms and signs of pharyngitis
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single
Eligibility Criteria
- Ages
- 18 Years to 70 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Male and female outpatients, aged 18 to 70 years, suffering from acute pharyngitis, pharyngolaryngitis
- •Moderately or severely intense pain in the pharyngeal region (score ≥ 70 mm) from the "visual analogue scale" (VAS)
- •At least 1 of the 2 inflammation signs (edema and hyperemia) to be moderately or severely intense (score ≥ 2) from the scoring scale from 0 to 3
- •Release of written informed consent by the patient
Exclusion Criteria
- •Patients suffering from a microbial infection requiring specific antimicrobial treatment
- •Patients who have taken the trial drugs during the week before enrolment
- •Patients who have taken corticosteroids or antibiotics during the week before enrolment
- •Ascertained or suspected hypersensitivity to trial drugs or to chemically correlated drugs or to other non-steroidal anti-inflammatory drugs or to mouthwashes in general
- •Patients who are unable to properly fill in the diary every day as provided for by the protocol
- •Ascertained or presumed pregnant or lactating women
- •Inclusion in any other clinical trial during the study
Arms & Interventions
Benzidamine hydrochloride
Active Comparator
Intervention: Benzidamine hydrochloride (Drug)
Ketoprofen lysine salt
Experimental
Intervention: Ketoprofen lysine salt (Drug)
Outcomes
Primary Outcomes
Duration of analgesic effects in hours
Time Frame: Up to 6 hours
Secondary Outcomes
- Average severity of edema and hyperemia, assessed by investigator on a 4-point-scale(Up to day 8)
- Average number of days required to obtain remission of pain(Up to day 8)
Investigators
Similar Trials
Completed
Not Applicable
A Study in Dentinal Hypersensitivity (DH) Participants to Assess the Efficacy of an Occluding Dentifrice.Dentin SensitivityNCT02753075GlaxoSmithKline240
Completed
Not Applicable
Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief From Dentinal HypersensitivityDentin SensitivityNCT02542943GlaxoSmithKline240
Completed
Not Applicable
Clinical Trial of a Mouth and Throat Rinse for the Treatment of Acute Sore ThroatSore-throatUpper Respiratory InfectionNCT06244615Dr. August Wolff GmbH & Co. KG Arzneimittel154
Completed
Not Applicable
Treatment of Group A Beta Hemolytic Streptococcal Pharyngitis in Children in Low Resource SettingsStreptococcal InfectionsPharyngitisNCT01156740Johns Hopkins University558
Completed
Not Applicable
Effect of Intermittent Oral Enteral Nutrition Tube in Tracheostomized Patients With Intracerebral HemorrhageIntracerebral HemorrhageNCT06304051Muhammad118
